Quantum BioPharma closes debt settlement of CAD$123,487.43 through share issuance

Corporate Action
โดย GlobeNewswire·Read original
Summary · why it matters

Quantum BioPharma has closed the settlement of CAD$123,487.43 in debt owed to arm’s length creditors and insiders through the issuance of Class B subordinate voting shares. The shares were issued at a deemed price of CAD$3.99 per Class B Share, representing the closing price on the Canadian Securities Exchange on the trading day immediately prior to the closing date. In full settlement of the debt, the company issued an aggregate of 30,948 Class B Shares to the creditors.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks
© 2026 MarketDXNews